Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table Adaptive Radiation Therapy, also known as SMART.
Tag: targeted cancer therapy
Liver Cancer’s Supercharged Metabolism Offers a New Treatment Strategy, Penn Study Suggests
Data published in Cell Metabolism on liver cancer’s rapid growth which leads to a vulnerability in its energy-production and cell-building processes that may be potently exploited with a new combination-treatment strategy, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
MD Anderson and Turning Point Therapeutics announce strategic alliance to advance precision cancer therapies
MD Anderson and Turning Point Therapeutics announced a strategic research and development alliance to evaluate Turning Points investigational targeted therapies against ROS1, NTRK, MET and other cancer drivers.
ORNL meets key FDA milestone for cancer-fighting Ac-225 isotope
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs. The U.S. Food and Drug Administration recently received Oak Ridge National Laboratory’s drug master file for actinium-225 nitrate, which lets pharmaceutical companies reference the document to support applications for their own Ac-225-based drugs without disclosing proprietary information.